Pasar al contenido principal

NUEVAS PLATAFORMAS DE MULTIPLEXADO ELECTROANALITICAS PARA LA DETECCION Y PRONOSTICO DE ENFERMEDADES NEOPLASICAS MEDIANTE BIOPSIAS LIQUIDAS

CTQ2015-64402-C2-1-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2015
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Dirección General de Investigación Científica y Técnica
Centro beneficiario UNIVERSIDAD COMPLUTENSE DE MADRID
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 18
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Comparison of Different Strategies for the Development of Highly Sensitive Electrochemical Nucleic Acid Biosensors Using Neither Nanomaterials nor Nucleic Acid Amplification

  • Ruiz Valdepeñas Montiel, Víctor
  • Povedano Muñumel, Eloy
  • Vargas, Eva
  • Torrente Rodríguez, Rebeca Magnolia
  • Pedrero Muñoz, María
  • Reviejo García, Ángel Julio
  • Campuzano Ruiz, Susana
  • Pingarrón Carrazón, José Manuel
Currently, electrochemical nucleic acid-based biosensing methodologies involving hybridization assays, specific recognition of RNA/DNA and RNA/RNAduplexes, and amplification systems provide an attractive alternative to conventional quantification strategies for the routine determination of relevant nucleic acids at different settings. A particularly relevant objective in the development of such nucleic acid biosensors is the design of as many as possible affordable, quick, and simple methods while keeping the required sensitivity. With this aim in mind, this work reports, for the first time, a thorough comparison between 11 methodologies that involve different assay formats and labeling strategies for targeting the same DNA. The assayed approaches use conventional sandwich and competitive hybridization assays, direct hybridization coupled to bioreceptors with affinity for RNA/DNA duplexes, multienzyme labeling bioreagents, and DNA concatamers. All of them have been implemented on the surface of magnetic beads (MBs) and involve amperometrictransduction at screen-printed carbon electrodes (SPCEs). The influence of the formed duplex length and of the labeling strategy have also been evaluated. Results demonstrate that these strategies can provide very sensitive methods without the need for using nanomaterials or polymerase chain reaction (PCR). In addition, the sensitivity can be tailored within several orders of magnitude simply by varying the bioassay format, hybrid length or labeling strategy. This comparative study allowed us to conclude that the use of strategies involving longer hybrids, the use of antibodies with specificity for RNA/DNA heteroduplexes and labeling with bacterial antibody binding proteins conjugated with multiple enzyme molecules, provides the best sensitivity.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Electrochemical biosensor for the simultaneous determination of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in human serum

  • Guerrero Irigoyen, Sara
  • Sánchez Tirado, Esther
  • Martínez-García, Gonzalo
  • González Cortés, Araceli
  • Yáñez-Sedeño Orive, Paloma
  • Pingarrón Carrazón, José Manuel
This paper reports a dual electrochemical biosensor involving carboxylated- or neutravidin-functionalized magnetic microbeads and dual screen-printed carbon electrodes for the simultaneous determination of rheumatoid factor (RF) and anti-cyclic citrullinated peptide (CCPA) autoantibodies used as biomarkers for the detection of rheumatoid arthritis autoimmune disease. Sandwich-type biosensors involving Fc fragments of IgG Fc(IgG) and biotinylated cyclic cytrullinated peptide (CCP-biotin) to form CCP-biotin-Neutr-MBs for the specific immobilization of RF and CCPA, respectively, as well as conjugation with HRP-IgM and HRP-IgG for RF and CCPA, respectively, were prepared. Amperometric detection was performed at −0.20 V vs. Ag pseudo-reference electrode using the H2O2/hydroquinone (HQ) system upon capturing the bioconjugates onto the corresponding working electrode (WE1 or WE2) of SPCdEs. The dual biosensor exhibits high sensitivity for RF and CCPA with LOD values of 0.8 and 2.5 IU mL−1, respectively. The simultaneous determination can be completed in about two hours using a simple protocol and a sample volume (25 μL) four times smaller than that required by the ELISA method. The dual electrochemical biosensor was used for the determination of both target biomarkers in human serum.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Magnetic beads-based electrochemical immunosensing of HIF-1α, a biomarker of tumoral hipoxia

  • Muñoz San Martín, Cristina
  • Gamella Carballo, María
  • Pedrero Muñoz, María
  • Montero Calle, Ana
  • Barderas Manchado, Rodrigo
  • Campuzano Ruiz, Susana
  • Pingarrón Carrazón, José Manuel
Hypoxia-inducible factor-1 alpha (HIF-1α) is a transcription factor involved in tumor growth and metastasis by regulating genes involved in response to hypoxia. This work reports the first magnetic beads (MBs)-based electrochemical immunoassay for the determination of HIF-1α. The design involves a sandwich immunoassay using MBs and amperometric detection at disposable screen-printed carbon electrodes (SPCEs). Magnetic immunoconjugates of carboxylic acid-microsized magnetic particles (HOOC-MBs) modified with a specific antibody were used to selectively capture the target protein which was sandwiched with a biotinylated secondary antibody further conjugated with a streptavidin peroxidase conjugate (Strep-HRP). The great analytical performance of the immunoassay in terms of selectivity and low limit of detection (76 pg mL−1) for HIF-1α allows the determination of the endogenous amount of this biomarker in 0.5 μg raw cancer cells lysates cultured in normoxia or induced-hypoxia with CoCl2. In addition, the developed immunosensing approach was employed to analyze HIF-1α in saliva samples with results that agree with those provided by an ELISA kit involving the same immunoreagents.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Electrochemical detection of peanuts at trace levels in foods using a magnetoimmunosensor for the allergenic protein Ara h 2

  • Ruiz Valdepeñas Montiel, Víctor
  • Pellicanò, Alessandro
  • Campuzano Ruiz, Susana
  • Torrente Rodríguez, Rebeca Magnolia
  • Reviejo García, Ángel Julio
  • Cosio, Maria Stella
  • Pingarrón Carrazón, José Manuel
A highly sensitive disposable amperometric magnetoimmunosensor for the rapid determination of Ara h 2 protein, one of the major peanut allergens, is reported. The approach uses a sandwich configuration involving selective capture and detector antibodies and carboxylic acid-modified magnetic beads (HOOC-MBs). Detector antibodies are labeled with HRP-conjugated secondary antibodies and the MBs bearing the immunoconjugates are magnetically captured on surface of a disposable screen-printed carbon electrode (SPCE). The affinity reactions are monitored amperometrically at −0.20 V (vs a Ag pseudo-reference electrode) in the presence of hydroquinone (HQ) as electron transfer mediator and upon addition of hydrogen peroxide as the enzyme substrate. The developed magnetoimmunosensor exhibits a wide range of linearity between 87 and 10,000 pg/mL Ara h 2 with a detection limit of 26 pg/mL as well as a great selectivity against other non-target proteins. The magnetoimmunosensing platform was successfully applied for the detection of Ara h 2 in different food extracts. After an appropriate sample dilution no matrix effects were observable. The developed methodology was able to detect trace amounts of the peanut allergen (0.0005% or 5.0 mg/kg) in wheat flour spiked samples. The results correlated properly with those provided by a commercial ELISA kit.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Fast Electrochemical miRNAs Determination in Cancer Cells and Tumor Tissues with Antibody-Functionalized Magnetic Microcarriers

  • Torrente Rodríguez, Rebeca Magnolia
  • Ruiz Valdepeñas Montiel, Víctor
  • Campuzano Ruiz, Susana
  • Farchado-Dinia, Meryem
  • Barderas Manchado, Rodrigo
  • San Segundo Acosta, Pablo
  • Montoya Miñano, Juan José
  • Pingarrón Carrazón, José Manuel
Microribonucleic acids (miRNAs) have been linked with various regulatory functions and diseases and constitute important targets in future medical diagnostics and prognostics. We report here a novel sensitive and rapid bioelectrochemical strategy for miRNA determination. This strategy involves the development of a sensing approach making use of magnetic beads (MBs) modified with a specific DNA-RNA antibody as capture bioreceptor and amperometric detection implying the H2O2/hydroquinone (HQ) system at disposable screen-printed carbon electrodes (SPCEs). The developed biosensor exhibits a dynamic range from 8.2 to 250 pM and a detection limit of 2.4 pM (60 amol) of a synthetic target without any amplification step in 2 h. The usefulness of the approach was evaluated by analyzing total RNA (RNAt) extracted from metastatic cancer cell lines and human tumor tissues, which demonstrated its potential to perform determination of mature miRNAs in these complex samples. Moreover, the feasibility of the developed methodology to detect simultaneously the expression of two different miRNAs at dual SPCEs (SPdCEs) in one single experiment was also explored. The feasibility to capture and release target miRNAs make the developed methodology also an attractive tool to isolate, purify, and determine target miRNAs with great applicability in the clinical field.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Amperometric determination of endoglin in human serum using disposable immunosensors constructed with poly(pyrrolepropionic) acid-modified electrodes

  • Martínez-Periñán, Emiliano
  • Sánchez-Tirado, E.
  • González-Cortés, Araceli
  • Barderas, Rodrigo
  • Sánchez-Puelles, José María
  • Martínez-Santamaría, Lucía
  • Campuzano, Susana
  • Yáñez-Sedeño, Pilar
  • Pingarrón, José Manuel
24 p.-6 fig.-2 tab., An amperometric immunosensor for the determination of the biomarker endoglin (CD105) to comply with the requirements of sensitivity and accuracy demanded in clinical practice is reported in this work. The immunosensing platform is implemented onto disposable electrodes modified with poly(pyrrolepropionic) acid (pPPA). The methodology involves a sandwich configuration and labeling of the biotinylated detector antibody with poly-HRP-streptavidin for signal amplification. Amperometric detection of hydrogen peroxide reduction in the presence of HQ was employed as analytical readout. The different steps involved in the immunosensor preparation were monitored by electrochemical impedance spectroscopy. The resulting immunosensor provided a linear range between 0.18 and 20 ng mL-1, adequate for the determination of CD105 in serum, with a detection limit (LOD) of 140 pg mL−1. These analytical characteristics improve those reported previously for other electrochemical immunosensors. A comparison with immunosensors prepared using other electrochemical scaffolds for anti-CD105 immobilization involving carboxylated doubled walled carbon nanotubes or modification by grafting, showed that a better performance was achieved using pPPA-modified SPCEs. A good reproducibility of the measurements, an excellent storage stability of the anti-CD105-pPPA/SPCE bioplatforms and an excellent selectivity of the resulting immunosensors were found. The usefulness of the immunosensors was tested by analyzing human serum samples collected from healthy individuals and patients of colorectal, breast and lung cancer and epidermolysis bullosa. The results were successfully validated against those provided by an ELISA kit., The financial support of the Spanish Ministerio de Economía y Competitividad CTQ2015-70023-R and CTQ2015-64402-C2-1-R, and SAF2014-53209-R Research Projects, the PI17CIII/00045 research project from AESI and the NANOAVANSENS Program from the Comunidad de Madrid (S2013/MT-3029)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Comparative evaluation of the performance of electrochemical immunosensors using magnetic microparticles and nanoparticles. Application to the determination of tyrosine kinase receptor AXL

  • Serafín, Verónica
  • Batlle, M.
  • García de Frutos, Pablo
  • Campuzano, Susana
  • Yáñez-Sedeño, Pilar
Electrochemical sandwich immunoassay strategies involving the use of carboxyl-functionalized magnetic microbeads (cMBs) and magnetic nanoparticles (cMNPs) have been evaluated and compared. The proteolytically cleaved soluble tyrosine kinase receptor sAXL was used as the target analyte. Antibodies against AXL were covalently immobilized on cMBs or cMNPs. Immunobinding of AXL was detected by means of a secondary biotinylated antibody and a streptavidin-horseradish peroxidase conjugate. The electrochemical transduction was accomplished by capturing the cMBs or cMNPs bearing the immunoconjugates onto screen-printed carbon electrodes (SPCEs) by using a small magnet. The amperometric response was measured at −0.20 V (vs the silver pseudo-reference electrode of the SPCE) upon the addition of H2O2 in the presence of hydroquinone as the redox mediator. The calibration plots for AXL extended up to 7.5 ng mL−1 when cMBs were used for the preparation of the immunosensor and up to 40 ng mL−1 in the case of using cMNPs. The respective slope values were 158 (cMBs) and 43 nA mL ng−1 (cMNPs), while the achieved LODs were 74 (cMBs) and 75 pg mL−1 (cMNPs). Although the immunosensors prepared with cMBs provided a shorter range of linearity, they exhibited a 3.7-times larger sensitivity than those constructed with cMNPs. The successful application of the new strategies was demonstrated for the determination of the endogenous content of sAXL in real human serum samples (a cut-off value of 71 ng mL−1 have been established for patients with risk of heart failure). The immunosensors constructed using cMBs or cMNPs can be advanta geously compared, in terms of sensitivity and fabrication time, with the only immunosensor for AXL previously reported. In addition, these new immunosensors took approximately half time than ELISA to perform the assay., The financial support of projects: Retos Colaboración RTC-2015-4184-1 (cofinanced by the Ministry of Economy and Competitivity and FEDER Buna manera de hacer Europa^), CTQ2015-70023-R and CTQ2015-64402-C2-1-R (Spanish Ministry of Economy and Competitivity Research Projects) and S2013/ MT-3029 (NANOAVANSENS Program from the Comunidad de Madrid) are gratefully acknowledged. R.M. Torrente-Rodríguez acknowledges a predoctoral contract from the Spanish Ministry of Economy and Competitivity, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Electrochemical immunosensor for receptor tyrosine kinase AXL using poly(pyrrolepropionic acid)-modified disposable electrodes

  • Serafín, Verónica
  • Torrente-Rodríguez, Rebeca M.
  • Batlle, Montserrat
  • García de Frutos, Pablo
  • Campuzano, Susana
  • Yáñez-Sedeño, Pilar
  • Pingarrón, José Manuel
A sensitive and rapid method for the determination of the clinically relevant biomarker receptor tyrosine kinase AXL in serum involving amperometric disposable immunosensors is reported. The target protein was sandwiched between a specific capture antibody covalently immobilized on screen-printed carbon electrodes modified with electropolymerized poly(pyrrolepropionic acid) and a biotinylated detector antibody labeled with a streptavidin-horseradish peroxidase conjugate. The amperometric responses were measured at −0.20 V vs the Ag pseudo-reference electrode of the SPCE upon the addition of H2O2 in the presence of hydroquinone (HQ) as mediator. This integrated immunosensing platform showed a low limit of detection (337 pg mL−1), a good selectivity against other non-target serum proteins, and provided results statistically in agreement with those obtained by using a commercial ELISA kit. These attractive features together with the simplicity and easy automation and miniaturization of the required instrumentation make the developed methodology a promising alternative in the development of devices for on-site clinical analysis., The financial support of projects: Retos Colaboración RTC2015-4184-1 (cofinanced by the Ministry of Economy and Competitivity and FEDER), CTQ2015-70023-R and CTQ2015- 64402-C2-1-R (Spanish Ministry of Economy and Competitivity Research Projects) and S2013/MT-3029 (NANOAVANSENS Program from the Comunidad de Madrid) are gratefully acknowledged. R.M. Torrente-Rodríguez acknowledges a predoctoral contract from the Spanish Ministerio de Economía y Competitividad., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An electrochemical immunosensor for brain natriuretic peptide prepared with screen-printed carbon electrodes nanostructured with gold nanoparticles grafted through aryl diazonium salt chemistry

  • Serafín, Verónica
  • Torrente-Rodríguez, Rebeca M.
  • González-Cortés, Araceli
  • García de Frutos, Pablo
  • Sabaté, Manel
  • Campuzano, Susana
  • Yáñez-Sedeño, Pilar
  • Pingarrón, José Manuel
A sensitive amperometric immunosensor has been prepared by immobilization of capture antibodies onto gold nanoparticles (AuNPs) grafted on a screen-printed carbon electrode (SPCE) through aryl diazonium salt chemistry using 4-aminothiophenol (AuNPs-S-Phe-SPCE). The immunosensor was designed for the accurate determination of clinically relevant levels of B-type natriuretic peptide (BNP) in human serum samples. The nanostructured electrochemical platform resulted in an ordered layer of AuNPs onto SPCEs which combined the advantages of high conductivity and improved stability of immobilized biomolecules. The resulting disposable immunosensor used a sandwich type immunoassay involving a peroxidase-labeled detector antibody. The amperometric transduction was carried out at −0.20 V (vs the Ag pseudo-reference electrode) upon the addition of hydroquinone (HQ) as electron transfer mediator and H2O2 as the enzyme substrate. The nanostructured immunosensors show a storage stability of at least 25 days, a linear range between 0.014 and 15 ng mL−1, and a LOD of 4 pg mL−1, which is 100 times lower than the established cut-off value for heart failure (HF) diagnosis. The performance of the immunosensor is advantageously compared with that provided with immunosensors prepared by grafting SPCE with p-phenylendiamine (H2N-Phe-SPCE) and attaching AuNPs by immersion into an AuNPs suspension or by electrochemical deposition, as well as with immunosensors constructed using commercial AuNPs-modified SPCEs. The developed immunosensor was applied to the successful analysis of human serum from heart failure (HF) patients upon just a 10-times dilution as sample treatment., The financial support of projects: RetosColaboración RTC-2015- 4184-1 (cofinanced by the Ministry of Economy and Competitivity and FEDER “una manera de hacer Europa”), CTQ2015-70023-R and CTQ2015-64402-C2-1-R (Spanish Ministry of Economy and Competitivity Research Projects) and S2013/MT-3029 (NANOAVANSENS Program from the Comunidad de Madrid) are gratefully acknowledged. R.M. Torrente-Rodríguez acknowledges a predoctoral contract from the Spanish Ministerio de Economía y Competitividad., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Detection of B-type natriuretic peptide (BNP) at screen printed carbon electrodes modified with gold nanoparticles grafted through aryl diazonium salt chemistry

  • Serafín, Verónica
  • Torrente-Rodríguez, Rebeca M.
  • Batlle, Montserrat
  • García de Frutos, Pablo
  • Campuzano, Susana
  • Yáñez-Sedeño, Pilar
  • Pingarrón, José Manuel
Trabajo presentado en la XXI Reunión de la Sociedad Española de Química Analítica, celebrada en Valencia, del 5 al 7 de septiembre de 2017, A key step in the proper functioning of an electrochemical biosensor is the surface architecture connecting the biological sample to the transducer. The type of materials involved, its geometry and size strongly affect the response of the biosensor. Furthermore, gold nanoparticles (AuNPs) have a strong capacity for biomolecules adsorption without losing of biological activity and facilitate the electron transfer between redox biomaterial and the electrode surface. Thus, immobilization of AuNPs on bulk electrodes using covalently attached organic layers containing thiol groups and amino groups on their distal end offers a simple, fast, and versatile approach for preparing nanoparticle electrode arrays with low background capacitance. On the order hand, since the signs and symptoms of heart failure (HF) are not very specific and the availability of echocardiography is limited, a very interesting alternative approach to diagnosis HF is to determine accurately the blood concentration of natriuretic peptides (NPs). Between them, the B-type natriuretic peptide (BNP) is a 32-amino acid polypeptide secreted by the ventricles of the heart in response to excessive stretching of heart muscle cells. Interestingly, it has been found that BNP concentration in serum is elevated in HF patients compared to controls, establishing a cut-off value of 400 pg mL-1 . With the purpose to develop a competitive electrochemical strategy for the accurate determination of clinically relevant levels of BNP in serum samples, in this work, we have prepared a sensitive electrochemical immunosensor for this polypeptide determination based on the immobilization of capture antibodies onto gold nanoparticles grafted through aryl diazonium salt chemistry onto screen-printed carbon electrodes (SPCEs) by means of a sandwich type immunoassay involving a peroxidase-labeled detector antibody. This novel nanostructured platform resulted in an ordered layer of gold nanoparticles adsorbed onto 4-aminothiophenol which combines the advantages of the high conductivity and the stability of immobilized biomolecules. To monitor the extension of the affinity reactions the amperometric transduction at disposable screen-printed carbon electrodes was performed at -200 mV (vs the Ag pseudo-reference electrode) upon addition of hydroquinone (HQ) as electron transfer mediator and H2O2 as the enzyme substrate. After optimizing all the experimental variables affecting the operation and response of this immunosensing approach its analytical performance was characterized and their practical applicability successfully demonstrated by analysis of real human serum samples. The promising analytical performance exhibited by this new amperometric immunosensor of simple operation, disposable SPCE format and possibility to use pocket-size electrochemical transducers makes it very attractive alternative to commonly used ELISAs for the development of automated POC systems for on-site determination of this powerful biomarker associated with HF., The financial support of projects: Retos Colaboración RTC-2015-4184-1 (cofinanced by the Ministry of Economy and Competitivity and FEDER “una manera de hacer Europa”), CTQ2015-70023-R and CTQ2015-64402-C2-1-R (MINECO Research Projects) and S2013/MT-3029 (NANOAVANSENS Program from the Comunidad de Madrid) are gratefully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Determination of cadherin-17 in tumor tissues of different metastatic grade using a single incubation-step amperometric immunosensor

  • Valverde, Ángela M.
  • Povedano, Eloy
  • Ruiz-Valdepeñas Montiel, Víctor
  • Yáñez-Sedeño, Paloma
  • Garranzo Asensio, María
  • Rodríguez, Nuria
  • Domínguez, Gemma
  • Barderas, Rodrigo
  • Campuzano, Susana
  • Pingarrón, José Manuel
This paper reports the development of an amperometric immunosensing platform for the determination of cadherin-17 (CDH-17), an atypical adhesion protein involved in the progression, metastatic potential, and survival of high prevalence gastric, hepatocellular, and colorectal tumors. The methodology developed relies on the efficient capture and enzymatic labeling of the target protein on the magnetic microparticles (MBs) surface using commercial antibodies and amperometric transduction at screen-printed carbon electrodes (SCPEs) through the HRP/H2O2/HQ system. The developed immunosensing platform allows the selective determination of the target protein at low ng mL-1 level (LOD of 1.43 ng mL-1) in 45 min and using a single incubation step. The electrochemical immunosensor was successfully used for the accurate determination of the target protein in a small amount (0.5 μg) of raw lysates of colon cancer cells with different metastatic potential as well as in extracts from paraffin embedded cancer colon tissues of different metastatic grade., The financial support of the Spanish Ministerio de Economía y Competitividad, Grants CTQ2015-70023-R and CTQ2015-64402-C2-1-R, and the NANOAVANSENS Program from the Comunidad de Madrid (Grant S2013/MT-3029), and predoctoral contracts from the Spanish Ministerio de Economia y Competitividad (E.P.) and Universidad Complutense de Madrid (V.R.-V.M.) are grate fully acknowledged. R.B. acknowledges the financial support of the PI17CIII/00045 Grant from the AES-ISCIII program. M.G.-A. was supported by a contract of the Programa Operativo de Empleo Juvenil y la Iniciativa de Empleo Juvenil (YEI) with the participation of the Consejería de Educacion, Juventud y Deporte de la Comunidad de Madrid y del Fondo Social Europeo., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

11PS04 is a new chemical entity identified by microRNA-based biosensing with promising therapeutic potential against cancer stem cells

  • Aguado, Tania
  • Romero-Revilla, José A.
  • Granados, R.
  • Campuzano, Susana
  • Torrente-Rodríguez, Rebeca M.
  • Cuesta, Ángel M.
  • Albiñana, Virginia
  • Botella, Luisa María
  • Santamaría, Silvia
  • García-Sanz, José A.
  • Pingarrón, José Manuel
  • Sánchez-Sancho, Francisco
  • Sánchez-Puelles, José María
13 p.-5 fig-1 tab., Phenotypic drug discovery must take advantage of the large amount of clinical data currently available. In this sense, the impact of microRNAs (miRs) on human disease and clinical therapeutic responses is becoming increasingly well documented. Accordingly, it might be possible to use miR-based signatures as phenotypic read-outs of pathological status, for example in cancer. Here, we propose to use the information accumulating regarding the biology of miRs from clinical research in the preclinical arena, adapting it to the use of miR biosensors in the earliest steps of drug screening. Thus, we have used an amperometric dual magnetosensor capable of monitoring a miR-21/miR-205 signature to screen for new drugs that restore these miRs to non-tumorigenic levels in cell models of breast cancer and glioblastoma. In this way we have been able to identify a new chemical entity, 11PS04 ((3aR,7aS)-2-(3-propoxyphenyl)-7,7a-dihydro-3aH-pyrano[3,4-d]oxazol-6(4H)-one), the therapeutic potential of which was suggested in mechanistic assays of disease models, including 3D cell culture (oncospheres) and xenografts. These assays highlighted the potential of this compound to attack cancer stem cells, reducing the growth of breast and glioblastoma tumors in vivo. These data demonstrate the enhanced chain of translatability of this strategy, opening up new perspectives for drug-discovery pipelines and highlighting the potential of miR-based electro-analytical sensors as efficient tools in modern drug discovery., This work was supported by grants CTQ2014-52213-R, CTQ2015-64402-C2-1-R and CTQ2015-64402-C2-2-R (Spanish Ministry of Economy and Competitiveness, MINECO), CM S2011/BMED-2353 (Comunidad de Madrid), and FEDER Funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Disposable amperometric immunosensor for the determination of the E‐cadherin tumor suppressor protein in cancer cells and human tissues

  • Muñoz-San Martín, Cristina
  • Pedrero, María
  • Villena, F. Javier Manuel de
  • Garranzo Asensio, María
  • Rodríguez, Nuria
  • Domínguez, Gemma
  • Barderas, Rodrigo
  • Campuzano, Susana
  • Pingarrón, José Manuel
This paper describes the results obtained in the development of the first electrochemical immunosensor described to date for the detection of E‐cadherin (E‐cad) protein, a relevant biomarker of prognosis and metastasis in cancer, based on the use of magnetic microcarriers (MBs) and amperometric transduction at screen‐printed carbon electrodes (SPCEs). Thus, the determination of E‐cad protein involved the use of two specific antibodies against this protein (one of them labelled with HRP) in a sandwich configuration onto HOOC‐MBs. The magnetic bioconjugates were captured onto SPCEs and the amperometric transduction was performed using the H2O2/hydroquinone (HQ) system. Under optimal conditions, this bioplatform demonstrated a wide linear concentration range (0.50–25 ng mL−1) and a detection limit as low as 0.16 ng mL−1, well below the optimal cut‐off level for the E‐cad protein (defined as 10,000 ng mL−1 for soluble E‐cad levels in serum). The developed sensor also showed a good reproducibility among measurements with seven different sensors constructed in the same manner (RSD, 5.4 %), stability for more than 15 days and good specificity towards other proteins commonly found on biological samples. The applicability of this simple handling bioplatform for the direct determination of this protein in cell lysates with different metastatic potential and extracts from paraffined‐embedded human colorectal cancer tissues of different grade were also demonstrated., The financial support of the Spanish Ministerio de Economía y Competitividad (CTQ2015‐64402‐C2‐1‐R Project) and the NANOAVANSENS Program from the Comunidad de Madrid (S2013/MT‐3029 Project) are gratefully acknowledged. C.M.S.M. was supported by a contract of the S2013/MT‐3029 Project. R.B. acknowledges the financial support of the PI17CIII/00045 grant from the AES‐ISCIII program. M.G.A. was supported by a contract of the Programa Operativo de Empleo Juvenil y la Iniciativa de Empleo Juvenil (YEI) with the participation of the Consejería de Educación, Juventud y Deporte de la Comunidad de Madrid y del Fondo Social Europeo., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Disposable amperometric immunosensor for the detection of adulteration in milk through single or multiplexed determination of bovine, ovine, or caprine immunoglobulins G

  • Ruiz-Valdepeñas Montiel, Víctor
  • Povedano, Eloy
  • Benedé, Sara
  • Mata, Luis
  • Galán-Malo, Patricia
  • Gamella, María
  • Reviejo, A. Julio
  • Campuzano, Susana
  • Pingarrón, José Manuel
This paper reports the first immunoplatforms for the detection of adulteration in milk with milk or colostrum from other animals. The developed electrochemical bioplatforms allow the reliable determination of immunoglobulins G (IgGs) from cows, sheeps, or goats. They rely on sandwiching each animal species-specific IgGs with selective antibody pairs [unconjugated and conjugated with horseradish peroxidase (HRP)] onto magnetic microbeads (MBs) used as solid supports and amperometric transduction with the H2O2/hydroquinone (HQ) system at disposable electrodes. The immunoplatforms allow achieving limits of detection (LODs) of 0.74, 0.82, and 0.66 ng mL–1 for bovine, ovine, and caprine IgGs, respectively, which are lower than those obtained with conventional enzyme-linked immunosorbent assay (ELISA) methodologies and in 2–5 times shorter time. The bioplatforms were successfully applied to the determination of the individual content of the target IgGs in milk samples of different animals (cow, sheep, and goat) and type (colostrum, raw, and pasteurized), without matrix effect and after just a sample dilution. They were also applied to the detection of adulteration with milks from other animals at levels below than those required by the European legislation (1.0%, v/v). The possibility to detect milk adulteration with colostrum using a strategy based on the measurement of the total content of the three target IgGs in raw milks is also demonstrated. Multiplexing platforms were constructed to be used in routine surveillance of milk. They are able to provide in a single run and in just 30 min relevant information regarding the milk sample including its animal origin, the undergone heat treatment, and whether it was adulterated with milk or colostrum from other species., The financial support of the Spanish Ministerio de Economía y Competitividad, CTQ2015-64402-C2-1-R Research Project, and the TRANSNANOAVANSENS Program from the Comunidad de Madrid (P2018/NMT-4349), and predoctoral contracts from the Spanish Ministerio de Economía y Competitividad (E.P.) and Universidad Complutense de Madrid (V.R.-V.M.) are gratefully acknowledged. S.B. acknowledges the financial support from MINECO through the “Juan de la Cierva” program., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Raloxifene and n-acetylcysteine ameliorate TGF-signalling in fibroblasts from patients with recessive dominant epidermolysis bullosa

  • Aguado, Tania
  • García, Marta
  • García, Adela
  • Ferrer-Mayorga, Gemma
  • Martínez-Santamaría, Lucía
  • Río, Marcela del
  • Botella, Luisa María
  • Sánchez-Puelles, José María
Recessive dystrophic epidermolysis bullosa (RDEB) is a severe skin disease caused by mutation of the COL7A1 gene. RDEB is associated with high levels of TGF-β1, which is likely to be involved in the fibrosis that develops in this disease. Endoglin (CD105) is a type III coreceptor for TGF-β1 and its overexpression in fibroblasts deregulates physiological Smad/Alk1/Alk5 signalling, repressing the synthesis of TGF-β1 and extracellular matrix (ECM) proteins. Raloxifene is a specific estrogen receptor modulator designated as an orphan drug for hereditary hemorrhagic telangiectasia, a rare vascular disease. Raloxifene stimulates endoglin synthesis, which could attenuate fibrosis. By contrast, the antioxidant N-acetylcysteine may have therapeutic value to rectify inflammation, fibrosis and endothelial dysfunction. Thus, we present here a repurposing strategy based on the molecular and functional screening of fibroblasts from RDEB patients with these drugs, leading us to propose the repositioning of these two well-known drugs currently in clinical use, raloxifene and N-acetylcysteine, to counteract fibrosis and inflammation in RDEB. Both compounds modulate the profibrotic events that may ultimately be responsible for the clinical manifestations in RDEB, suggesting that these findings may also be relevant for other diseases in which fibrosis is an important pathophysiological event., This work was supported by grants CTQ2014-52213-R, CTQ2015-64402-C2-1-R and CTQ2015-64402-C2-2-R (Spanish Ministry of Economy and Competitiveness, MINECO), CM S2011/BMED-2353 (Comunidad de Madrid), and FEDER Funds and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) (ISCIII)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multiplexed monitoring of a novel autoantibody diagnostic signature of colorectal cancer using HaloTag technology-based electrochemical immunosensing platform

  • Garranzo Asensio, María
  • Guzmán-Aránguez, Ana I.
  • Povedano, Eloy
  • Ruiz-Valdepeñas Montiel, Víctor
  • Povés, Carmen
  • Fernandez-Aceñero, M. Jesús
  • Montero-Calle, Ana
  • Solís-Fernández, Guillermo
  • Fernández-Díez, Servando
  • Camps, Jordi
  • Arenas, Meritxell
  • Rodríguez-Tomàs, Elisabeth
  • Joven, Jorge
  • Sánchez-Martínez, María Cruz
  • Rodríguez, Nuria
  • Domínguez, Gemma
  • Yáñez-Sedeño, Paloma
  • Pingarrón, José Manuel
  • Campuzano, Susana
  • Barderas, Rodrigo
[Background and Purpose]: The humoral immune response in cancer patients can be used for early detection of the disease. Autoantibodies raised against tumor-associated antigens (TAAs) are promising clinical biomarkers for reliable cancer diagnosis, prognosis, and therapy monitoring. In this study, an electrochemical disposable multiplexed immunosensing platform able to integrate difficult- and easy-to-express colorectal cancer (CRC) TAAs is reported for the sensitive determination of eight CRC-specific autoantibodies., [Methods]: The electrochemical immunosensing approach involves the use of magnetic microcarriers (MBs) as solid supports modified with covalently immobilized HaloTag fusion proteins for the selective capture of specific autoantibodies. After magnetic capture of the modified MBs onto screen-printed carbon working electrodes, the amperometric responses measured using the hydroquinone (HQ)/H2O2 system were related to the levels of autoantibodies in plasma., [Results]: The biosensing platform was applied to the analysis of autoantibodies against 8 TAAs described for the first time in this work in plasma samples from healthy asymptomatic individuals (n=3), and patients with high-risk of developing CRC (n=3), and from patients already diagnosed with colorectal (n=3), lung (n=2) or breast (n=2) cancer. The developed bioplatform demonstrated an improved discrimination between CRC patients and controls (asymptomatic healthy individuals and breast and lung cancer patients) compared to an ELISA-like luminescence test., [Conclusions]: The proposed methodology uses a just-in-time produced protein in a simpler protocol, with low sample volume, and involves cost-effective instrumentation, which could be used in a high-throughput manner for reliable population screening to facilitate the detection of early CRC patients at affordable cost., This work was supported by the financial support of the PI17CIII/00045 grant from the AES-ISCIII program to R.B., cofounded by FEDER funds. The financial support of the CTQ2015-64402-C2-1-R (Spanish Ministerio de Economía y Competitividad) and RTI2018-096135-B-I00 (Ministerio de Ciencia, Innovación y Universidades) Research Projects and the TRANSNANOAVANSENS-CM Program from the Comunidad de Madrid (Grant S2018/NMT-4349) to P.Y-S., S.C. and JM.P are gratefully acknowledged. G.D. acknowledges the financial support of PI15/00246 grant of the FIS and Cátedra UAM-Roche en Medicina de Innovación. M.G-A. was supported by a contract of the Programa Operativo de Empleo Juvenil y la Iniciativa de Empleo Juvenil (YEI) with the participation of the Consejería de Educación, Juventud y Deporte de la Comunidad de Madrid y del Fondo Social Europeo. A.M-C. is a recipient of a FPU fellowship from the Ministerio de Educación, Cultura y Deporte. G.S-F. is recipient of a predoctoral contract (grant number 1193818N) supported by The Flanders Research Foundation (FWO). Predoctoral contracts from the Spanish Ministerio de Economía y Competitividad (E.P.) and Universidad Complutense de Madrid (V.R.V-M.) are also gratefully acknowledged., Peer reviewed
Docta Complutense
Publicación Artículo científico (JournalArticle)

Disposable Amperometric Immunosensor for the Detection of Adulteration in Milk through Single or Multiplexed Determination of Bovine, Ovine, or Caprine Immunoglobulins G

  • Ruiz Valdepeñas Montiel, Víctor
  • Povedano Muñumel, Eloy
  • Benedé Pérez, Sara
  • Mata, Luis
  • Galán-Malo, Patricia
  • Gamella Carballo, María
  • Reviejo García, Ángel Julio
  • Campuzano Ruiz, Susana
  • Pingarrón Carrazón, José Manuel
This paper reports the first immunoplatforms for the detection of adulteration in milk with milk or colostrum from other animals. The developed electrochemical bioplatforms allow the reliable determination of immunoglobulins G (IgGs) from cows, sheeps, or goats. They rely on sandwiching each animal species-specific IgGs with selective antibody pairs [unconjugated and conjugated with horseradish peroxidase (HRP)] onto magnetic microbeads (MBs) used as solid supports and amperometric transduction with the hydrogen peroxide/hydroquinone (HQ) system at disposable electrodes. The immunoplatforms allow achieving limits of detection (LODs) of 0.74, 0.82, and 0.66 ng/mL for bovine, ovine, and caprine IgGs, respectively, which are lower than those obtained with conventional enzyme-linked immunosorbent assay (ELISA) methodologies and in 2–5 times shorter time. The bioplatforms were successfully applied to the determination of the individual content of the target IgGs in milk samples of different animals (cow, sheep, and goat) and type (colostrum, raw, and pasteurized), without matrix effect and after just a sample dilution. They were also applied to the detection of adulteration with milks from other animals at levels below than those required by the European legislation (1.0%, v/v). The possibility to detect milk adulteration with colostrum using a strategy based on the measurement of the total content of the three target IgGs in raw milks is also demonstrated. Multiplexing platforms were constructed to be used in routine surveillance of milk. They are able to provide in a single run and in just 30 min relevant information regarding the milk sample including its animal origin, the undergone heat treatment, and whether it was adulterated with milk or colostrum from other species.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Electrochemical magnetic beads-based immunosensing platform for the determination of α-lactalbumin in milk

  • Ruiz Valdepeñas Montiel, Víctor
  • Campuzano Ruiz, Susana
  • Torrente Rodríguez, Rebeca Magnolia
  • Reviejo García, Ángel Julio
  • Pingarrón Carrazón, José Manuel
Alpha-lactalbumin (α-LA) is one of the whey proteins in cows’ milk that has been identified as allergenic. In this work, we present, for the first time, a very sensitive magnetic beads (MBs)-based immunosensor for the determination of α-LA. A sandwich configuration involving selective capture and horseradish peroxidase-labeled detector antibodies was implemented on carboxylic acid-modified magnetic beads, captured magnetically under the surface of a disposable screen-printed carbon electrode for amperometric detection using the hydroquinone (HQ)/hydrogen peroxide system. The α-LA immunosensor exhibited a wide linear range (37.0–5000 pg/ml), a low limit of detection (LOD, 11.0 pg/ml) and noteworthy selectivity against other non-target proteins. The MBs-based immunosensing platform was applied successfully for the determination of α-LA in several varieties of milk (raw and UHT cows’ milk as well as human milk) and infant formulations. The results were corroborated with those obtained using a commercial ELISA method, thereby substantiating the analytical merits of this unique method.